Publikationen in Zusammenarbeit mit Forschern von Hospital Regional Universitario de Málaga (13)

2023

  1. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  2. Nosocomial COVID-19: A Nationwide Spanish Study

    Gerontology, Vol. 69, Núm. 6, pp. 671-683

  3. Prognostic Factors Associated with Acute Heart Failure in Patients Admitted for COVID-19: Analysis of the SEMI-COVID-19 Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

2022

  1. Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

    Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775

  2. Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  3. Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19

    PLoS ONE, Vol. 17, Núm. 1 January

  4. Prone Position in COVID-19 Patients With Severe Acute Respiratory Distress Syndrome Receiving Conventional Oxygen Therapy: A Retrospective Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 277-280

2021

  1. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry

    Journal of General Internal Medicine, Vol. 36, Núm. 10, pp. 3080-3087

  2. Evolution of the use of corticosteroids for the treatment of hospitalised COVID-19 patients in Spain between March and November 2020: SEMI-COVID national registry

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  3. Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

    Drugs, Vol. 81, Núm. 6, pp. 685-695

  4. Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study

    Journal of General Internal Medicine, Vol. 36, Núm. 5, pp. 1338-1345

2018

  1. Dalbavancin in the treatment of different gram-positive infections: a real-life experience

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577

2016

  1. Efecto de una intervención sobre indicadores de calidad para mejorar el tratamiento de la hiperglucemia en pacientes hospitalizados en áreas no críticas

    Revista Clinica Espanola, Vol. 216, Núm. 7, pp. 352-360